Gates Foundation
Published May 1, 2021 | Version Accepted Version
Journal article Open

Repurposing Infectious Disease Hits as Anti-Cryptosporidium Leads

Creators

  • 1. Department of Medicine Division of Allergy Infectious Disease Center for Emerging Reemerging Infectious Diseases, University of Washington, Seattle, Washington 98109, United States
  • 2. Department of Pathobiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States
  • 3. Calibr, a division of The Scripps Research Institute, La Jolla, California 92037, United States
  • 4. Department of Biochemistry, University of Washington, Seattle, Washington 98195, United States
  • 5. Medicines Development Campus, Global Health Pharma Unit, GlaxoSmithKline, Tres Cantos, 28760, Madrid Spain
  • 6. Academic Liaison, GlaxoSmithKline, Upper Providence, Pennsylvania 19426, United States
  • 7. Medicinal Chemistry, GlaxoSmithKline, Tres Cantos, 28760, Madrid Spain

Description

This is the accepted manuscript version of the work published in its final form as Hulverson, M. A., Choi, R., McCloskey, M. C., Whitman, G. R., Ojo, K. K., Michaels, S. A., Somepalli, M., Love, M. S., McNamara, C. W., Rabago, L. M., Barrett, L. K., Verlinde, C. L., Arnold, S. L. M., Striepen, B., Jimenez-Alfaro, D., Ballell, L., Fernández, E., Greenwood, M. N., las Heras, L. de, … Van Voorhis, W. C. (2021). Repurposing infectious disease hits as anti-cryptosporidium leads. ACS Infectious Diseases, 7(5), 1275–1282. https://doi.org/10.1021/acsinfecdis.1c00076.

Deposited by shareyourpaper.org and openaccessbutton.org. We've taken reasonable steps to ensure this content doesn't violate copyright. However, if you think it does you can request a takedown by emailing help@openaccessbutton.org.

Files

Files (909.4 kB)